Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update

Go back to Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
(NASDAQ: AXSM) Delayed: 205.49 -2.29 (1.1%)
Previous Close $207.78    52 Week High $15.74 
Open $208.17    52 Week Low $5.37 
Day High $210.85    P/E N/A 
Day Low $203.38    EPS $0.00 
Volume 543,355